QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,018 signal articles · 475 in last 24h · 106,345 total before filter · latest 36m ago
475last 24h
2472last 7d
474● bullish (7d)
249● bearish (7d)
200publishers
AllMacro178Earnings1540M&A130Regulatory15Product8Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Could Micron Hit $2 Trillion? The Price Target Just Tripled
24/7 Wall St.70d agoneutral
Could Micron Hit $2 Trillion? The Price Target Just Tripled

Micron Technology (NASDAQ:MU) is the story nobody saw coming. Twelve months ago you could buy a share for under a hundred dollars. On Tuesday this week it briefly cleared a trillion-dollar valuation, joined the same afternoon by SK Hynix, and Wall Street started openly asking whether the next stop is two. The catalyst was simple ... Could Micron Hit $2 Trillion? The Price Target Just Tripled

UnitedHealth (UNH) Gets Higher Price Target from Bernstein Amid EPS Recovery Outlook
Insider Monkey71d agoneutral
UnitedHealth (UNH) Gets Higher Price Target from Bernstein Amid EPS Recovery Outlook

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Safe Stocks to Buy for the Long Term in 2026. On May 27, Bernstein raised the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) to $492 from $444 and maintained an Outperform rating on the shares. The new target implies 27% upside potential. The firm said […]

Cisco (CSCO) Gets Higher Price Target From BofA Following Q3 Results
Insider Monkey71d agoneutral
Cisco (CSCO) Gets Higher Price Target From BofA Following Q3 Results

Cisco Systems, Inc. (NASDAQ:CSCO) is included among the 10 Safe Stocks to Buy for the Long Term in 2026. On May 26, BofA raised the firm’s price target on Cisco Systems, Inc. (NASDAQ:CSCO) to $135 from $114. It reiterated a Buy rating on the shares. The analyst said Cisco’s recent fiscal Q3 results, along with […]

A Look At Generac Holdings (GNRC) Valuation After Data Center Engine Upgrade Tailwind
Simply Wall St.71d agobullish
A Look At Generac Holdings (GNRC) Valuation After Data Center Engine Upgrade Tailwind

A recent upgrade from a major investment bank has put fresh attention on Generac Holdings (GNRC), after analysts pointed to the company’s role supplying heavy-duty engines for commercial data centers and a potential large hyperscaler contract. See our latest analysis for Generac Holdings. The Jefferies upgrade has landed after a strong run, with a 30 day share price return of 27.34% and a year to date share price return of 98.82%. The 1 year total shareholder return of 125.23% sits alongside...

Sea Limited (SE) Outlook Strengthens as Barclays Maintains Overweight Rating
Insider Monkey71d agoneutral
Sea Limited (SE) Outlook Strengthens as Barclays Maintains Overweight Rating

We recently compiled a list of the 10 Most Widely Held Stocks by Individuals in 2026. Sea Limited (NYSE:SE) is one of the most widely held stocks by individuals. TheFly reported on May 14 that Barclays lifted its price objective on Sea Limited (NYSE:SE) to $122 from $120 and maintained an Overweight rating on the […]

Is Cipher Digital Inc. (CIFR) a Strong Buy as Morgan Stanley Raises Price Target?
Insider Monkey71d agobullish
Is Cipher Digital Inc. (CIFR) a Strong Buy as Morgan Stanley Raises Price Target?

We recently compiled a list of the 12 Best Strong Buy Tech Stocks to Invest In Now. Cipher Digital Inc. (NASDAQ:CIFR) is among the best Strong Buy stocks on this list. TheFly reported on May 19 that Morgan Stanley increased its price target on CIFR to $42.50 from $40.50 while maintaining an Overweight rating on the stock. […]

MRVL Q1 Deep Dive: Data Center Growth and AI Demand Drive Outlook Upgrade
StockStory71d agobullish
MRVL Q1 Deep Dive: Data Center Growth and AI Demand Drive Outlook Upgrade

Networking chips designer Marvell Technology (NASDAQ: MRVL) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 27.6% year on year to $2.42 billion. The company expects next quarter’s revenue to be around $2.7 billion, coming in 3% above analysts’ estimates. Its non-GAAP profit of $0.80 per share was in line with analysts’ consensus estimates.

Is TransDigm’s Upgraded 2026 Outlook After Strong Q2 Results Altering The Investment Case For TDG?
Simply Wall St.71d agobullish
Is TransDigm’s Upgraded 2026 Outlook After Strong Q2 Results Altering The Investment Case For TDG?

Earlier in May 2026, TransDigm Group reported Q2 results with revenue and adjusted EPS above analyst forecasts and raised its full-year 2026 outlook, reflecting solid demand for its aerospace components. The upgraded guidance highlights how stronger-than-expected operating momentum may influence expectations for the company’s earnings power and cash generation profile. Next, we’ll examine how TransDigm’s upgraded 2026 outlook following its strong Q2 performance could reshape the company’s...

Citi sets bold Pershing Square stock price target for 2026
TheStreet71d agoneutral
Citi sets bold Pershing Square stock price target for 2026

Bill Ackman finally took the keys to Pershing Square public in April, and Wall Street is now beginning to weigh in on what that company is actually worth. Citi was the first major bank to argue it could be worth a lot more than the market currently thinks. On Tuesday, May 26, the firm initiated ...

Intuitive Surgical (ISRG) Is Pushing 100 Upgrades to Its da Vinci 5 Robot Starting June
Insider Monkey71d agobullish
Intuitive Surgical (ISRG) Is Pushing 100 Upgrades to Its da Vinci 5 Robot Starting June

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical technology stocks to buy right now. On May 21, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced a major round of updates to its da Vinci 5 robotic surgical system, including extended instrument use capabilities. The company said more than 100 improvements will roll out to US customers […]

Why Jefferies Raised Teladoc Health Inc (TDOC) Stock Price Target
Insider Monkey71d agoneutral
Why Jefferies Raised Teladoc Health Inc (TDOC) Stock Price Target

Teladoc Health Inc (NYSE:TDOC) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. On May 1, Jefferies raised its price target Teladoc shares to $6 from $5.20 while keeping a Hold rating on the stock. Even so, the firm’s new price target remains below Teladoc’s current […]

Bernstein Maintains Outperform Rating on UnitedHealth (UNH) Following PBM Transparency Push
Insider Monkey72d agobullish
Bernstein Maintains Outperform Rating on UnitedHealth (UNH) Following PBM Transparency Push

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best stocks for a couch potato portfolio. On May 15, Bernstein SocGen Group maintained its Outperform rating and $444 price target for UnitedHealth Group Incorporated (NYSE:UNH). The firm touched on UnitedHealth’s recently introduced transparent pharmacy benefit manager (PBM) approach, which aims to improve clarity, reliability, and cost in […]

BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results
Insider Monkey72d agoneutral
BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results

Pfizer Inc. (NYSE:PFE) ranks among the best retirement stocks to buy now. On May 5, BofA Securities boosted its price objective for Pfizer Inc. (NYSE:PFE) to $27 from $26, retaining a Neutral rating on the company shares. Following Pfizer’s first-quarter performance, the firm raised its fiscal 2026 revenue and earnings per share forecasts. The pharmaceutical […]

Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress
Insider Monkey72d agoneutral
Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress

AbbVie Inc. (NYSE:ABBV) ranks among the best retirement stocks to buy now. Piper Sandler increased its price target for AbbVie Inc. (NYSE:ABBV) to $298 from $294 on May 14, retaining an Overweight rating on the company’s shares. The firm mentioned AbbVie’s extensive inflammatory bowel disease pipeline as a major source of investor interest. AbbVie Inc. […]

Arete Upgrades Okta, Inc. (OKTA) Rating to Buy
Insider Monkey72d agobullish
Arete Upgrades Okta, Inc. (OKTA) Rating to Buy

Okta, Inc. (NASDAQ:OKTA) is one of the 10 Best Cybersecurity Stocks to Buy According to Short Sellers. On May 26, TheFly reported that Arete analyst Ellie Kearney upgraded Okta’s rating to Buy from Sell, setting a price target of $127 price target. The analyst said it expects a “modest beat-and-raise” quarter for Okta, driven by […]